Financial toxicity is the negative patient level impact of the cost of cancer care and is unfortunately a side effect of cancer for too many Australians. Despite the known negative psychological and physical impacts of financial toxicity on people affected by cancer, it is only in recent years that financial toxicity has become a priority for clinicians, researchers, and health services to address. As the opening presentation in the delegate-designed symposium hosted by the COSA Financial Toxicity Working Group, this presentation will provide an overview of the COSA definition of financial toxicity in cancer care, update delegates on work to address financial toxicity in Australia including the Standard for Informed Financial Consent, and outline work underway within the COSA Financial Toxicity Working Group.